Skip to content

JMJ PHARMA

Active Private limited companyfounded 2021active for 5 yearsRue Jules Hagnoul 1, 1350 Orp-JaucheKBO/BCE: BE 0766.337.513 #7 company by total assets in Orp-Jauche, Wholesale and retail trade sector

Annual accounts 2025

abbreviated format, filed on 08-06-2026, 53 days before the deadline
€167,539
▼ 4.1%
€15,617
▼ 42.8%
€76,068
▼ 15.9%
€62,351
▼ 19.1%
13.1%
▲ 1.0 percentage points
1.26
▼ 0.11

Money flows

no detail for 2025

Balance sheet

balance sheet total €850,094 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

13.1%

Higher than 22% of the 13,303 companies filing abbreviated accounts in retail trade (NACE 47) in 2025.

1.26

Higher than 38% of the 13,162 companies filing abbreviated accounts in retail trade (NACE 47) in 2025.

0.2%

Higher than 25% of the 13,223 companies filing abbreviated accounts in retail trade (NACE 47) in 2025.

JMJ PHARMA Middle half of the sector 80% of the sector Abbreviated accounts in retail trade (NACE 47)

Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: middle half · Staff: middle half

Staff

€49,334

Staff costs divided by the average number of full-time equivalents.

employees who joined employees who left

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend202520242023202220219 months
76,06890,40688,19542,64377,876
62,35177,11575,15131,18163,274
0-01,6654,261900,036
6,432-484-22,211-50,177-
49,54862,97361,03661,426110,052
----2.3%5.1%
13.1%12.2%10.1%8.3%10.7%
1.261.371.381.331.64
0.430.420.360.470.74
6.627.228.9511.008.38
1.7%12.8%9.3%-40.1%17.8%
0.2%1.6%0.9%-3.3%1.9%
7.007.906.923.678.65
---20 days17 days
---35 days35 days

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend202520242023202220219 months
Balance sheet: assets
20/58 850,094901,327951,9321.0m1.1m
21/28 607,997668,448731,535796,652858,360
21 256,000304,000352,000400,000448,000
22/27 351,647364,099379,186395,802410,010
22 350,056361,391372,727384,062395,398
23 1,5922,4233,2542,2812,946
24 -2853,2059,45911,667
28 349349349849349
29/58 242,097232,879220,397245,357282,414
3 159,983162,108163,172159,647155,237
30/36 159,983162,108163,172159,647155,237
40/41 67,16461,76348,16954,03844,033
40 64,65961,76348,16954,03844,033
41 2,505----
54/58 14,9508,5189,00231,21381,390
490/1 -490544591,755
Balance sheet: equity and liabilities
10/49 850,094901,327951,9321.0m1.1m
10/15 111,605109,70695,67886,809121,597
10/11 100,000100,000100,000100,000100,000
14 11,6059,706-4,322-13,19121,597
17/49 738,488791,621856,254955,2001.0m
17 545,939621,715696,823771,269845,060
170/4 545,939621,715696,823771,269845,060
42/48 192,549169,906159,361183,931172,362
42 75,77575,10874,44673,79173,142
44 86,10076,59566,21380,06772,590
440/4 86,10076,59566,21380,06772,590
45 30,67318,20318,70230,07326,630
450/3 8,9114,9604,8999,72410,787
454/9 21,76213,24313,80320,34915,844
47/48 0-000
492/3 0-71-1,755
Income statement
70 ---999,544710,817
9900 167,539174,760209,270182,605142,444
60/61 ---825,727572,468
62 88,80181,618119,508138,57263,816
630 60,45263,08766,28265,96941,677
640/8 2,6702,7361,5681,390752
9901 15,61727,31921,913-23,32636,199
75/76B 207643314210
75 207643314210
65/66B 10,85911,43712,74511,6059,003
65 10,85911,43712,74511,6059,003
9903 4,96515,9469,201-34,78827,206
67/77 3,0651,918332-5,609
9904 1,90014,0288,869-34,78821,597
9905 1,90014,0288,869-34,78821,597
Appropriation of the result
9906 11,6059,706-4,322-13,19121,597
14P 9,706-4,322-13,19121,597-
Social balance sheet
9087 1.81.72.42.82.7
Hours worked1013 2,5282,6173,5244,2622,375
Document PDFPDFPDFPDFPDF

The full notes are in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 08-06-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 abbreviated format 08-06-2026 2026-00164774 PDF
31-12-2024 full format 29-07-2025 2025-00334178 PDF
31-12-2023 micro format 11-06-2024 2024-00138008 PDF
31-12-2022 micro format 02-06-2023 2023-00116791 PDF
31-12-2021 micro format 29-06-2022 2022-20156744 PDF

Social balance sheet

Item31-12-202531-12-202431-12-202331-12-202231-12-2021
Employees at the balance-sheet date33344
full-time--122
part-time33222
in full-time equivalents1.81.71.82.82.8
1.81.72.42.82.5
On a permanent contract33343
Joined-10-4
Left-11-3

Source: social balance sheet in the 2021 to 2025 annual accounts

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets--€1,665€3,761€419,687
Intangible fixed assets----€480,000
Financial fixed assets---€500€349
€60,452€63,087€66,282€65,969€41,677

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on JMJ PHARMA

The operating result for 2025 is 43% lower than in 2024 and the lowest since 2022.

Debt's share of the balance-sheet total falls from 87.8% to 86.9%. Equity is higher and debt is lower.

Next steps